Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on World Health News Pakistan.
IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance
GlobeNewswire, Inc.
·
May 8, 2025
Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quarters Adjusted EPS of $0.82 - an increase of 18% to prior year quarter Makes strategic entry into India - launching with leading healthcare client Board authorizes a...
Memo: Governor Kathy Hochul’s Appearance Before the House Committee on Oversight and Government Reform
New York State Office of the Governor
·
June 12, 2025
TO: Interested Parties FROM: Office of Governor Kathy Hochul DATE: June 12, 2025 RE: Governor Kathy Hochul’s Appearance Before the U.S. House Committee on Oversight and Government Reform...
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
GlobeNewswire, Inc.
·
March 20, 2025
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition...
AIDA Country Report on Ireland – 2024 Update
European Council on Refugees and Exiles (ECRE)
·
June 9, 2025
|Published on: 9th June 2025|Categories: News| The updated AIDA Country Report on Ireland provides a detailed overview on legislative and practice-related developments in asylum procedures, reception conditions, detention of asylum applicants and...
R3 Stem Cell Wins 2025 Award for Leading Innovators in Regenerative Cell Therapy
EIN Presswire
·
May 6, 2025
SCOTTSDALE, AZ, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- R3 Stem Cell has won the 2025 Award for Leading Innovators in Regenerative Cell Therapy. As the global leader in stem cell and exosome treatments, this makes the fifth straight...
Terror attack kills more than 26 in India’s Kashmir
MENAFN
·
April 29, 2025
(MENAFN) At least 26 people were killed in Jammu and Kashmir on Tuesday when gunmen opened fire at close range, according to reports from local Indian police sources. The terrorist group, The Resistance Front (TRF), which has links to the...
Global Times: Readers’ Reflections: China is reshaping the global innovation landscape, says Italian scholar
GlobeNewswire, Inc.
·
June 4, 2025
Beijing, China, June 04, 2025 (GLOBE NEWSWIRE) -- May 30, 2025 marks the ninth National Science and Technology Workers Day. In the early morning of the previous day, Tianwen-2, the country's first asteroid probe and sampling mission, soared into...
Security Members Get Killed After Attack on Vaccination Team
MENAFN
·
April 24, 2025
(MENAFN) At least two security officers were killed and another injured during an ambush on a polio vaccination team in southwestern Pakistan on Wednesday, based on police reports. The attack took place in the Mastung district of Balochistan...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Valve Actuator Market Size is Anticipated to Grow at a CAGR of 5.3%, Reaching USD 24.62 billion by 2031 | The Insight Partners
GlobeNewswire, Inc.
·
April 25, 2025
US & Canada, April 25, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the Valve Actuator Market is observing significant growth owing to growing advancements in valve actuators and increasing growth in...
Alvotech Reports Record Results for 2024 and Provides Business Update
GlobeNewswire, Inc.
·
March 26, 2025
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted EBITDA in 2024 was $108.3 million compared to negative...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
GlobeNewswire, Inc.
·
January 27, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
GlobeNewswire, Inc.
·
January 27, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
March 18, 2025
HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
·
February 10, 2025
Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; international shipments to commence later this year...
Prima Consulting and Jubilee General Insurance Team Up to Implement Delta IFRS 17 Software
EIN Presswire
·
January 30, 2025
Leading insurer strengthens digital transformation strategy with innovative compliance software: Delta IFRS 17 Software. KARACHI, PAKISTAN, January 30, 2025 /EINPresswire.com/ -- November 2024 — Prima Consulting has announced a landmark...
Reko Diq JV Shareholders Approve Project, Select Fluor as EPCM
GlobeNewswire, Inc.
·
April 8, 2025
All amounts expressed in US dollars ISLAMABAD, April 08, 2025 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) – The Reko Diq Joint Venture shareholders have approved the project’s updated Feasibility Study and conditionally...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...